Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
RPTH Editorial Staff Bios
Share |

About RPTHSUBMIT A MANUSCRIPT | Author Guidelines | Staff List

 

RPTH Editorial Staff Bios

 

  Editor-in-Chief  
 

Mary Cushman, M.D., M.Sc., is Professor of Medicine and Pathology at the University of Vermont. She is a hematologist in the Department of Medicine at the University of Vermont Medical Center, where she is Director of the Thrombosis and Hemostasis Program, which sees more than 900 new patients annually. She is a Board Director of the University’s Cardiovascular Research Institute.

She completed M.D., residency and fellowship training at the University of Vermont and a Master of Science in Epidemiology at Harvard School of Public Health.

Cushman’s research interest is the study of causative factors for diseases of aging including heart disease, stroke, venous thrombosis, and their risk factors. Investigation of reasons for racial disparities are of particular interest. She is a Steering Committee member of the REasons for Geographic and Racial Differences in Stroke (REGARDS) study, a large population-based cohort study, and has been a key investigator of the Cardiovascular Health Study and the Multi-Ethnic Study of Atherosclerosis (MESA). She has had continuous NIH funding for 20 years.

Cushman is also a Board Director of the American Heart Association (AHA). She serves on the AHA Science Advisory Coordinating Committee, and the American Society of Hematology Committee on Quality of Care. She is immediate past Chair of the AHA Council Operations Committee, where she provided leadership to all 16 Scientific Councils and initiated an Early Career subcommittee with representation of all Councils. She is a past Chair of the AHA Science Council on Epidemiology and Prevention where efforts focused on early career member development and increasing scientific publishing. She also chaired that Council’s 46th & 47th Annual Scientific Conferences, and was a member of the AHA Manuscript Oversight Committee. She was on the organizing committee for ISTH-Boston, overseeing clinical thrombosis programming, and she developed specific early career programming at that ISTH Congress for the first time. She has served on numerous NIH working groups, workshops and study sections.

Cushman is experienced in scientific publishing, starting as an editorial board member for Archives of Internal Medicine in 2004-10, then as an Associate Editor for JTH from 2007-15, where she handled papers independently, serving the two most recent pairs of editors-in-chief. She regularly provided input to the editors on issues of substance to the journal. She was Guest Editor for Circulation from 2008-2011, then served from 2011-16 as Senior Guest Editor of Circulation for population science, independently handling papers that represented conflicts for the Boston editorial team. In this role she functioned like an editor in chief, supervising Guest Editors who obtained and evaluated results of peer review.

She was awarded the Distinguished Academic Achievement Award from the University of Vermont College of Medicine in 2009, the Senior Researcher of the Year Award from the University of Vermont Medical Center in 2012 and Distinguished Achievement Award from the Epidemiology and Prevention Council of AHA in 2014. She has an h-index of 98 and has authored over 450 peer-reviewed publications and 38 invited reviews or chapters. Her work has been cited over 77,000 times by others, with over 43,000 of these since 2011. A publication list can be found here

 
   Associate Editors  
 

Pantep Angchaisuksiri, M.D., is Professor of Medicine and Chief of the Haemostasis and Thrombosis Unit in the Division of Haematology, Department of Medicine, at Ramathibodi Hospital, Mahidol University in Bangkok, Thailand. He also holds posts of Adjunct Associate Professor of Medicine at the University of North Carolina at Chapel Hill, School of Medicine, North Carolina, and is Associate Director of the Bangkok International Haemophilia Training Centre of the World Federation of Haemophilia.

Angchaisuksiri is a medical graduate of Chulalongkorn University in Bangkok, Thailand and was trained in Internal Medicine at Prince of Songkla University and Haematology at Mahidol University. He was also a clinical and postdoctoral fellow in Haematology/Oncology at the Medical College of Virginia in Richmond, Virginia and the University of North Carolina at Chapel Hill, School of Medicine, North Carolina, USA.

An active clinician, Professor Angchaisuksiri works with patients with thrombosis, hemophilia and other bleeding disorders, and has authored and co-authored papers relating to hemostasis and thrombosis in several leading international scientific journals. He is a council member of the ISTH and the Asian-Pacific Society on Thrombosis and Hemostasis (APSTH), an editor of the APSTH newsletter, an editorial board member of the journals: Thrombosis Research, Journal Thrombosis, and Blood Research, and a member of several professional societies, including the American Society of Hematology, and the World Federation of Hemophilia. He is also a member of the ISTH Membership and Communications Committee, the ISTH Education and Outreach Committee, the ISTH Curriculum for Training in Thrombosis and HemostasisCommittee, and the ISTH Steering Committee for World Thrombosis Day.

 
  Cihan Ay, M.D., is an Associate Professor at the Medical University of Vienna in Austria. He studied medicine at the Medical Univeristy of Vienna and Ruprecht-Karls-University in Heidelberg, Germany. He earned his MD from the Medical University of Vienna in 2006 and received there his medical training and completed specialization in internal medicine, hematology and medical oncology.

Ay is currently a visiting research professor at the University of North Carolina at Chapel Hill, NC, USA (2016-2017). His research and clinical work focuses on venous thromboembolism (VTE), anticoagulation and bleeding disorders. Having contributed to over 100 peer-reviewed publications, he was particularly successful in contributing to a better understanding of the etiology of VTE in cancer by identifying biomarkers and clinical risk factors for cancer-associated VTE.

He has been an active peer reviewer for major medical journals in the field including the BMJ, Circulation, Blood, ATVB, Haematologica, Journal of Thrombosis and Haemostasis (JTH), Thrombosis Research and Thrombosis & Haemostasis (T&H), etc. He also serves as Co-Chair of the ISTH Scientific and Standardization Committee (SSC) Subcommittee on Hemostasis and Malignacy and on the Editorial Board of JTH.

Ay is a passionate clinician and researcher, supervisor of diploma and Ph.D.-students and maintains regular teaching activities for students and health care professionals to foster education in the field of thrombosis and hemostasis.

 
 

Suzanne Cannegieter, M.D., M.Sc., is a Professor of Clinical Epidemiology at the Leiden University Medical Center in the Netherlands. She focuses her research on venous thrombosis, with a particular interest in its aetiology, as well as in establishing optimal prevention and therapy. A few examples of topics include the relation between venous thrombosis and surgery, cancer, cardiovascular disease, air travel, female risk factors, endocrine hormones, infection and risk factors for recurrent thrombosis.

She is a member of the Education Committee of the Council of the ISTH, co-chair of the ISTH Scientific Subcommittee on Predictive and Diagnostic Variables, and was a member of the Local Organizing Committee (Education) for the 24th Congress of ISTH, held in Amsterdam 2013. She is a member of the Scientific Advisory Board of the Dutch Thrombosis Foundation, a member of the editorial boards of PLoS Medicine and the Journal of Thrombosis and Haemostasis (JTH) and a reviewer for various other journals and foundations.

 
 

Adam Cuker, M.D., M.Sc., is Assistant Professor of Medicine and Pathology & Laboratory Medicine at the University of Pennsylvania. He received his M.D. from Yale University and completed an internship and residency in internal medicine at Brigham and Women’s Hospital and Harvard Medical School. He continued his postgraduate training at the Hospital of the University of Pennsylvania where he was a fellow in hematology/oncology. He holds a Masters degree in Translational Research from the University of Pennsylvania.

Cuker is Director of the Penn Comprehensive Hemophilia & Thrombosis Program and Associate Director of the Penn-CHOP Blood Center for Patient Care and Discovery. He conducts NIH-funded patient-oriented research on heparin-induced thrombocytopenia, venous thromboembolism, and anticoagulation. He is Chair of the forthcoming American Society of Hematology guidelines on venous thromboembolism and Chair of the panel on heparin-induced thrombocytopenia. 

 
 

Susan Kahn, M.D., M.Sc., FRCPC, is a clinical epidemiologist and internist based at the Jewish General Hospital in Montreal, Quebec, Canada, where she is the founder and director of the Centre of Excellence in Thrombosis and Anticoagulation Care. She is appointed as Professor with Tenure in the Department of Medicine, McGill University, where she is Director of the McGill Thrombosis Fellowship. She is also co-Director of the CIHR-funded CanVECTOR Network, a Canadian national venous thromboembolism research and training network.

Kahn’s research interests focus primarily on clinical trials of interventions to prevent, diagnose, treat, and improve outcomes of venous thromboembolism. She holds a Tier 1 Canada Research Chair in Venous Thromboembolism, and previously held a National Clinical Research Scholar award from the Fonds de recherche du Québec-Santé (FRQ-S). She has been awarded numerous peer-reviewed research grants from national and provincial funding agencies, including a 7-year CIHR Foundation grant in 2015, and has published more than 200 papers in the field of thromboembolism. In 2016, she was elected to Fellowship in the Canadian Academy of Health Sciences (CAHS), considered one of the highest honors for members of the Canadian health sciences community. Also in 2016, she was awarded the Canadian Society of Internal Medicine (CSIM) Dr. David Sackett Senior Investigator Award. This award recognizes excellence in research by a senior Canadian general internist, and is intended to increase awareness of high-quality research by general internists in Canada and to foster such research.

 
 

Fiona Newall, Ph.D., M.S.N., is the Director of Nursing Research at Royal Children's Hospital in Melbourne, Australia. Newell commenced working in the field of pediatric thrombosis and anticoagulation in 1999. She completed her Masters in 2005 and Ph.D. in 2009, with both degrees exploring questions identified from clinical practice.

Fiona has published extensively within the field of pediatric thrombosis and anticoagulant management. In addition to her position as Director of Nursing Research at RCH, Fiona continues to work clinically within her field of pediatric anticoagulant management. She has an honorary professorial appointment at the University of Melbourne (departments of Pediatrics and Nursing) and is an honorary Research Fellow with the Murdoch Children's Research Institute.

 
 

Yotis Senis, Ph.D., M.Sc., is a British Heart Foundation Senior Research Fellow at the University of Birmingham. He was awarded a BScH in Life Sciences, and an M.Sc. and Ph.D. in Pathology from Queen’s University, Canada. His M.Sc. was with Alan Giles in one of the leading hemostasis and thrombosis groups, and Ph.D. was with Peter Greer on tyrosine phosphorylation and haematopoiesis. His postdoctoral training was with Steve Watson at the University of Oxford, characterizing novel receptors and signalling pathways regulating platelet activation and thrombosis.

In 2009, Senis was awarded a British Heart Foundation Intermediate Basic Science Research Fellowship and a Senior Fellowship in 2013.  In his research, he takes a multidisciplinary approach to elucidate how protein tyrosine phosphatases regulate platelet production and function, with the overall objective of identifying novel therapeutic targets for the treatment of thrombosis and bleeding disorders.

 
 

Alisa Wolberg, Ph.D., is currently Professor of Pathology and Laboratory Medicine with tenure at the University of North Carolina at Chapel Hill.

Wolberg’s expertise is in physiologic and pathophysiologic mechanisms in hemostasis and thrombosis including in vitro and in vivo models of bleeding and thrombotic disorders. She has a particular interest in the biochemical and physical contributions of cells and plasma proteins to thrombin generation and clot formation, structure and stability. Ongoing work in her laboratory includes studies on contributions of fibrin(ogen), transglutaminase factor XIII, and red blood cells to thrombosis, and elucidating mechanisms that mediate clot formation and stability in hemophilia and factor XI deficiency.

Wolberg is a member of the Council of the ISTH, Board of Directors of the North American Society of Thrombosis and Hemostasis, and Board of Counsillors of the International Fibrinogen Research Society. She also serves on organizing committees for the American Heart Association and American Society of Hematology, and will Chair the 2018 Gordon Research Conference on Hemostasis.

 

 

ABOUT RPTH | SUBMIT A MANUSCRIPT | Author Guidelines | Staff List

Membership Management Software Powered by YourMembership  ::  Legal